The healthcare expenditure on Over-The-Counter (OTC) medicines in Poland stood at 0.65% of GDP in 2023. Based on forecasted data, the expenditure remains relatively stable at 0.65% for the years 2024 and 2025, before experiencing a slight decline to 0.64% from 2026 through 2028. The year-on-year variation reflects a consistent annual reduction of approximately 1.54% from 2025 to 2026 and remains steady thereafter.
Considering the compound annual growth rate (CAGR) over the five-year forecast period (2024-2028), the average annual variation per year is minimal, underscoring a stable yet slightly decreasing trend in the expenditure on OTC medicines as a percentage of GDP.
Trends to watch for in the future include:
- Potential shifts in healthcare policy and funding priorities.
- Influence of new OTC product launches and consumer behavior changes.
- Impact of economic fluctuations on healthcare spending habits.
